Orris

1.K.L. Mansfield, D.L. Horton, N. Johnson, L. Li, A.D. Barrett, D.J. Smith, S.E. Galbraith, T. Solomon, A.R. Fooks Flavivirus-induced antibody cross-reactivity J. Gen. Virol., 92 (12) (2011), pp. 2821-2829 2.M. Ferrari, A. Zevini, E. Palermo, M. Muscolini, M. Alexandridi, M.P. Etna, E.M. Coccia, A. Fernandez-Sesma, C. Coyne, D.D. Zhang, E.T. Marques Dengue virus targets Nrf2 for NS2B3-mediated degradation leading to enhanced oxidative stress and viral replication J. Virol., 94 (24) (2020), pp. 3.I.A. Rodenhuis-Zybert, J. Wilschut, J.M. Smit Dengue virus life cycle: viral and host factors modulating infectivity Cell. Mol. Life Sci., 67 (2010), pp. 2773-2786) 10-1128 4.Pourzangiabadi M, Najafi H, Fallah A, Goudarzi A, Pouladi I. Dengue virus: Etiology, epidemiology, pathobiology, and developments in diagnosis and control - A comprehensive review. Infect Genet Evol. 2025 Jan;127:105710. doi: 10.1016/j.meegid.2024.105710. Epub 2024 Dec 26. PMID: 39732271. 5.J.B. Kathiriya, N.M. Shah, J.S. Patel, B.B. Javia, M.M. Tajpara, S.N. Ghodasara, D.B. Barad Epidemiological surveillance of Dengue fever: an overviewInt J Vet Sci Amin Hasb, 5 (6) (2020), pp. 1-10 6.M.T. Islam, C. Quispe, J. Herrera Bravo, C. Sarkar, R. Sharma, N. Garg, L.I. Fredes, M. Martorell, M.M. Alshehri, J. Sharifi-Rad, S.D. Daştan Production, transmission, pathogenesis, and control of dengue virus: a literature-based undivided perspective Biomed. Res. Int., 2021 (1) (2021), p. 4224816 7.B.H. Kok, H.T. Lim, C.P. Lim, N.S. Lai, C.Y. Leow, C.H. Leow Dengue virus infection–a review of pathogenesis, vaccines, diagnosis and therapy Virus Res., 324 (2023), Article 199018 8.P. Bhatt, S.P. Sabeena, M. Varma, G. Arunkumar Current understanding of the pathogenesis of dengue virus infection Curr. Microbiol., 78 (1) (2021), pp. 17-32 9.K.A. Dowd, D. Sirohi, S.D. Speer, L.A. VanBlargan, R.E. Chen, S. Mukherjee, B.M. Whitener, J. Govero, M. Aleshnick, B. Larman, S. Sukupolvi-Petty prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesis Proc. Natl. Acad. Sci., 120 (3) (2023), Article e2218899120 10. A. Khanam, H. Gutiérrez-Barbosa, K.E. Lyke, J.V. Chua Immune-mediated pathogenesis in dengue virus infection Viruses, 14 (11) (2022), p. 2575 11.A. Dhanoa, S.S. Hassan, C.F. Ngim, C.F. Lau, T.S. Chan, N.A. Adnan, W.W. Eng, H.M. Gan, G. Rajasekaram Impact of dengue virus (DENV) co-infection on clinical manifestations, disease severity and laboratory parameters BMC Infect. Dis., 16 (2016), pp. 1-4 12.M.B. Zaidi, L. Cedillo-Barron, M.E.G. Almeida, J. Garcia-Cordero, F.D. Campos, K. Namorado-Tonix, F. Perez Serological tests reveal significant cross-reactive human antibody responses to Zika and Dengue viruses in the Mexican population Acta Trop., 201 (2020), Article 105201 13. N.A. Muhammad Azami, T. Takasaki, I. Kurane, M.L. Moi Non-human primate models of dengue virus infection: a comparison of viremia levels and antibody responses during primary and secondary infection among old world and new world monkeys Pathogens, 9 (4) (2020), p. 247 14.A.T. Waickman, J.Q. Lu, H. Fang, M.J. Waldran, C. Gebo, J.R. Currier, L. Ware, L. Van Wesenbeeck, N. Verpoorten, O. Lenz, L. Tambuyzer Evolution of inflammation and immunity in a dengue virus 1 human infection model Sci. Transl. Med., 14 (668) (2022) 15. G.N. Malavige, C. Jeewandara, G.S. Ogg Dysfunctional innate immune responses and severe dengue Front. Cell. Infect. Microbiol., 10 (2020), Article 590004 16.A. Dhal, T. Kalyani, S. Ghorai, N.K. Sahu, S.K. Jana Recent development of electrochemical immunosensor for the diagnosis of dengue virus NSI protein: a review Sensors Int., 1 (2020), Article 100030 17.L.É. Marques, B.B. Silva, R.F. Dutra, E.O.T. Florean, R. Menassa, M.I.F. Guedes Transient expression of dengue virus NS1 antigen in Nicotiana benthamiana for use as a diagnostic antigen Front. Plant Sci., 10 (2020), p. 1674 18. D. Lokida, N. Lukman, G. Salim, D.P. Butar Butar, H. Kosasih, W.N. Wulan, A.M. Naysilla, Y. Djajady, R.A. Sari, D. Arlinda, C.Y. Lau Diagnosis of COVID-19 in a dengue-endemic area Am. J. Trop. Med. Hyg., 103 (3) (2020), p. 1220 19.Khan MB, Yang ZS, Lin CY, Hsu MC, Urbina AN, Assavalapsakul W, Wang WH, Chen YH, Wang SF. Dengue overview: An updated systemic review. J Infect Public Health. 2023 Oct;16(10):1625-1642. doi:10.1016/j.jiph.2023.08.001. Epub 2023 Aug 3. PMID: 37595484. 20.N.M. Pollak, M. Olsson, M. Ahmed, J. Tan, G. Lim, Y.X. Setoh, J.C.C. Wong, Y.L. Lai, J. Hobson-Peters, J. Macdonald, D. McMillan Rapid diagnostic tests for the detection of the four dengue virus serotypes in clinically relevant matrices Microbiology Spectrum, 11 (1) (2023) 21.D.B. Shrestha, P. Budhathoki, B. Gurung, S. Subedi, S. Aryal, A. Basukala, B. Aryal, A. Adhikari, A. Poudel, G.K. Yadav, M. Khoury Epidemiology of dengue in SAARC territory: a systematic review and meta-analysis Parasit. Vectors, 15 (1) (2022), p. 389 22. G.N. Malavige, C. Jeewandara, A. Ghouse, G. Somathilake, H. Tissera Changing epidemiology of dengue in Sri Lanka—challenges for the future PLoS Negl. Trop. Dis., 15 (8) (2021), Article e0009624 23. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805–12. doi: 10.1172/JCI200318921. 24. Vuong NL, Le Duyen HT, Lam PK, Tam DTH, Vinh Chau NV, Van Kinh N, Chanpheaktra N, Lum LCS, Pleités E, Jones NK, Simmons CP, Rosenberger K, Jaenisch T, Halleux C, Olliaro PL, Wills B, Yacoub S. C-reactive protein as a potential biomarker for disease progression in dengue: a multi-country observational study. BMC Med. 2020 Feb 17;18(1):35. doi: 10.1186/s12916-020-1496-1. PMID: 32063229; PMCID: PMC7025413. 25. Lobo V, Kumar MV. Role of biomarkers and its trend to predict the outcome of COVID-19 patients: A retrospective study. Indian J Crit Care Med. 2022;26:1031–5. 26. Goyal PK, Hissaria K, Shekhawat C. Role of serum ferritin as a predictor of dengue severity: A prospective observational study from India. Cureus. 2024;16(6):e63503. 27. Cheng L, Li H, Li L, et al. Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. J Clin Lab Anal. 2020;34(10):e23618. 28.(. Suresh SC, Hanumanthaiah R, Ramakrishna C, Sandeep R, Narasimhasetty PS, Ramakrishna V, P BK, Raju B. Serum Ferritin As a Prognostic Indicator in Adult Dengue Patients. Am J Trop Med Hyg. 2020 Dec 28;104(3):1072-1078. doi: 10.4269/ajtmh.20-1111. PMID: 33372649; PMCID: PMC7941811.). 29.(. Rosso F, Parra-Lara LG, Agudelo-Rojas OL, Martinez-Ruiz DM. Differentiating dengue from COVID-19: Comparison of cases in Colombia. Am J Trop Med Hyg. 2021;105(3):745–50.). 30.(. Engelke M, Cynthia Sabrina Schmidt, Baldini G, et al. Optimizing platelet transfusion through a personalized deep learning risk assessment system for demand management. Blood. 2023;142(26):2315–26.). 31.(. Yuditya D, Sudirgo I. The relation between Neutrophil Lymphocyte Count Ratio (NLCR) and dengue infection grade of severity in adult patients in RS Muhammadiyah Ahmad Dahlan Kediri in January 2019. STRADA Jurnal Ilmiah Kesehatan, 2020;9(1):20-25. https://doi.org/10.30994/sjik.v9i1.265.). 32.(. Sadgir A, Durge K, Masavkar S. Neutrophil-lymphocyte ratio as a prognostic indicator in dengue fever patients at tertiary care hospital in Northwest Maharashtra. Int J Adv Res. 2023;11(1):1198–1202. doi:10.21474/IJAR01/16137) 33. Billett HH. Hemoglobin and hematocrit. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. Boston (MA): Butterworths; 1990. p. 718–9.. 34. Khazali AS, Hadrawi WH, Ibrahim F, et al. Thrombocytopenia in dengue infection: mechanisms and a potential application. Expert Rev Mol Med. 2024;26:e26. . 35. Yasuda I, Saito N, Suzuki M, et al. Unique characteristics of new complete blood count parameters, the immature platelet fraction and the immature platelet fraction count, in dengue patients. PLoS One. 2021;16(11):e0258936.). 36. Asha J, Baiju NM, Innah SJ, et al. Comparison of platelet indices in dengue fever patients based on platelet transfusion: A prospective observational study in a tertiary care center. Asian J Transfus Sci. 2023;17(1):21–7. 37.Pattnaik SS, Patil U, Aggarwal L, et al. Exploring mean platelet volume and platelet count recovery in dengue patients: Findings from an observational retrospective clinical study. Cureus. 2024;16(7):e65553. 42. Thach TQ, Eisa HG, Hmeda AB, Faraj H, Thuan TM, Abdelrahman MM, Awadallah MG, Ha NX, Noeske M, Abdul Aziz JM, Nam NH, Nile ME, Dumre SP, Huy NT, Hirayama K. Predictive markers for the early prognosis of dengue severity: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2021 Oct 5;15(10):e0009808. doi: 10.1371/journal.pntd.0009808. Erratum in: PLoS Negl Trop Dis. 2022 Jan 27;16(1):e0010164. doi: 10.1371/journal.pntd.0010164. PMID: 34610027; PMCID: PMC8519480. 43. Khazali AS, Hadrawi WH, Ibrahim F, Othman S, Nor Rashid N. Thrombocytopenia in dengue infection: mechanisms and a potential application. Expert Rev Mol Med. 2024 Oct 14;26:e26. doi: 10.1017/erm.2024.18. PMID: 39397710; PMCID: PMC11488332. 44. Mayrose H, Bairy GM, Sampathila N, Belurkar S, Saravu K. Machine Learning-Based Detection of Dengue from Blood Smear Images Utilizing Platelet and Lymphocyte Characteristics. Diagnostics (Basel). 2023 Jan 6;13(2):220. doi: 10.3390/diagnostics13020220. PMID: 36673030; PMCID: PMC9857931. CONVERT INTO VANCOUVER STYLE OF REFERENCE

Here are all references converted to Vancouver style:
  1. Mansfield KL, Horton DL, Johnson N, Li L, Barrett AD, Smith DJ, et al. Flavivirus-induced antibody cross-reactivity. J Gen Virol. 2011;92(12):2821–9.
  2. Ferrari M, Zevini A, Palermo E, Muscolini M, Alexandridi M, Etna MP, et al. Dengue virus targets Nrf2 for NS2B3-mediated degradation leading to enhanced oxidative stress and viral replication. J Virol. 2020;94(24).
  3. Rodenhuis-Zybert IA, Wilschut J, Smit JM. Dengue virus life cycle: viral and host factors modulating infectivity. Cell Mol Life Sci. 2010;67:2773–86.
  4. Pourzangiabadi M, Najafi H, Fallah A, Goudarzi A, Pouladi I. Dengue virus: Etiology, epidemiology, pathobiology, and developments in diagnosis and control - A comprehensive review. Infect Genet Evol. 2025 Jan;127:105710.
  5. Kathiriya JB, Shah NM, Patel JS, Javia BB, Tajpara MM, Ghodasara SN, et al. Epidemiological surveillance of Dengue fever: an overview. Int J Vet Sci Anim Husb. 2020;5(6):1–10.
  6. Islam MT, Quispe C, Herrera Bravo J, Sarkar C, Sharma R, Garg N, et al. Production, transmission, pathogenesis, and control of dengue virus: a literature-based undivided perspective. Biomed Res Int. 2021;2021:4224816.
  7. Kok BH, Lim HT, Lim CP, Lai NS, Leow CY, Leow CH. Dengue virus infection–a review of pathogenesis, vaccines, diagnosis and therapy. Virus Res. 2023;324:199018.
  8. Bhatt P, Sabeena SP, Varma M, Arunkumar G. Current understanding of the pathogenesis of dengue virus infection. Curr Microbiol. 2021;78(1):17–32.
  9. Dowd KA, Sirohi D, Speer SD, VanBlargan LA, Chen RE, Mukherjee S, et al. prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesis. Proc Natl Acad Sci USA. 2023;120(3):e2218899120.
  10. Khanam A, Gutiérrez-Barbosa H, Lyke KE, Chua JV. Immune-mediated pathogenesis in dengue virus infection. Viruses. 2022;14(11):2575.
  11. Dhanoa A, Hassan SS, Ngim CF, Lau CF, Chan TS, Adnan NA, et al. Impact of dengue virus (DENV) co-infection on clinical manifestations, disease severity and laboratory parameters. BMC Infect Dis. 2016;16:1–4.
  12. Zaidi MB, Cedillo-Barron L, Almeida MEG, Garcia-Cordero J, Campos FD, Namorado-Tonix K, et al. Serological tests reveal significant cross-reactive human antibody responses to Zika and Dengue viruses in the Mexican population. Acta Trop. 2020;201:105201.
  13. Muhammad Azami NA, Takasaki T, Kurane I, Moi ML. Non-human primate models of dengue virus infection: a comparison of viremia levels and antibody responses during primary and secondary infection among old world and new world monkeys. Pathogens. 2020;9(4):247.
  14. Waickman AT, Lu JQ, Fang H, Waldran MJ, Gebo C, Currier JR, et al. Evolution of inflammation and immunity in a dengue virus 1 human infection model. Sci Transl Med. 2022;14(668).
  15. Malavige GN, Jeewandara C, Ogg GS. Dysfunctional innate immune responses and severe dengue. Front Cell Infect Microbiol. 2020;10:590004.
  16. Dhal A, Kalyani T, Ghorai S, Sahu NK, Jana SK. Recent development of electrochemical immunosensor for the diagnosis of dengue virus NS1 protein: a review. Sensors Int. 2020;1:100030.
  17. Marques LÉ, Silva BB, Dutra RF, Florean EOT, Menassa R, Guedes MIF. Transient expression of dengue virus NS1 antigen in Nicotiana benthamiana for use as a diagnostic antigen. Front Plant Sci. 2020;10:1674.
  18. Lokida D, Lukman N, Salim G, Butar Butar DP, Kosasih H, Wulan WN, et al. Diagnosis of COVID-19 in a dengue-endemic area. Am J Trop Med Hyg. 2020;103(3):1220.
  19. Khan MB, Yang ZS, Lin CY, Hsu MC, Urbina AN, Assavalapsakul W, et al. Dengue overview: An updated systemic review. J Infect Public Health. 2023 Oct;16(10):1625–42.
  20. Pollak NM, Olsson M, Ahmed M, Tan J, Lim G, Setoh YX, et al. Rapid diagnostic tests for the detection of the four dengue virus serotypes in clinically relevant matrices. Microbiol Spectr. 2023;11(1).
  21. Shrestha DB, Budhathoki P, Gurung B, Subedi S, Aryal S, Basukala A, et al. Epidemiology of dengue in SAARC territory: a systematic review and meta-analysis. Parasit Vectors. 2022;15(1):389.
  22. Malavige GN, Jeewandara C, Ghouse A, Somathilake G, Tissera H. Changing epidemiology of dengue in Sri Lanka—challenges for the future. PLoS Negl Trop Dis. 2021;15(8):e0009624.
  23. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805–12.
  24. Vuong NL, Le Duyen HT, Lam PK, Tam DTH, Vinh Chau NV, Van Kinh N, et al. C-reactive protein as a potential biomarker for disease progression in dengue: a multi-country observational study. BMC Med. 2020;18(1):35.
  25. Lobo V, Kumar MV. Role of biomarkers and its trend to predict the outcome of COVID-19 patients: A retrospective study. Indian J Crit Care Med. 2022;26:1031–5.
  26. Goyal PK, Hissaria K, Shekhawat C. Role of serum ferritin as a predictor of dengue severity: A prospective observational study from India. Cureus. 2024;16(6):e63503.
  27. Cheng L, Li H, Li L, et al. Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. J Clin Lab Anal. 2020;34(10):e23618.
  28. Suresh SC, Hanumanthaiah R, Ramakrishna C, Sandeep R, Narasimhasetty PS, Ramakrishna V, et al. Serum ferritin as a prognostic indicator in adult dengue patients. Am J Trop Med Hyg. 2021;104(3):1072–8.
  29. Rosso F, Parra-Lara LG, Agudelo-Rojas OL, Martinez-Ruiz DM. Differentiating dengue from COVID-19: Comparison of cases in Colombia. Am J Trop Med Hyg. 2021;105(3):745–50.
  30. Engelke M, Schmidt CS, Baldini G, et al. Optimizing platelet transfusion through a personalized deep learning risk assessment system for demand management. Blood. 2023;142(26):2315–26.
  31. Yuditya D, Sudirgo I. The relation between Neutrophil Lymphocyte Count Ratio (NLCR) and dengue infection grade of severity in adult patients in RS Muhammadiyah Ahmad Dahlan Kediri in January 2019. STRADA J Ilm Kesehat. 2020;9(1):20–5.
  32. Sadgir A, Durge K, Masavkar S. Neutrophil-lymphocyte ratio as a prognostic indicator in dengue fever patients at tertiary care hospital in Northwest Maharashtra. Int J Adv Res. 2023;11(1):1198–202.
  33. Billett HH. Hemoglobin and hematocrit. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. Boston (MA): Butterworths; 1990. p. 718–9.
  34. Khazali AS, Hadrawi WH, Ibrahim F, Othman S, Nor Rashid N. Thrombocytopenia in dengue infection: mechanisms and a potential application. Expert Rev Mol Med. 2024;26:e26.
  35. Yasuda I, Saito N, Suzuki M, et al. Unique characteristics of new complete blood count parameters, the immature platelet fraction and the immature platelet fraction count, in dengue patients. PLoS One. 2021;16(11):e0258936.
  36. Asha J, Baiju NM, Innah SJ, et al. Comparison of platelet indices in dengue fever patients based on platelet transfusion: A prospective observational study in a tertiary care center. Asian J Transfus Sci. 2023;17(1):21–7.
  37. Pattnaik SS, Patil U, Aggarwal L, et al. Exploring mean platelet volume and platelet count recovery in dengue patients: Findings from an observational retrospective clinical study. Cureus. 2024;16(7):e65553.
  38. Thach TQ, Eisa HG, Hmeda AB, Faraj H, Thuan TM, Abdelrahman MM, et al. Predictive markers for the early prognosis of dengue severity: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2021;15(10):e0009808.
  39. Khazali AS, Hadrawi WH, Ibrahim F, Othman S, Nor Rashid N. Thrombocytopenia in dengue infection: mechanisms and a potential application. Expert Rev Mol Med. 2024;26:e26.
  40. Mayrose H, Bairy GM, Sampathila N, Belurkar S, Saravu K. Machine learning-based detection of dengue from blood smear images utilizing platelet and lymphocyte characteristics. Diagnostics (Basel). 2023;13(2):220.
Notes on Vancouver formatting applied:
  • Author surnames followed by initials, no punctuation between initials
  • Up to 6 authors listed; if more, first 6 are listed followed by "et al."
  • Journal names abbreviated
  • Volume(issue):pages format
  • Article numbers retained where no page range was available
  • DOIs and PMIDs omitted (Vancouver does not require them, though they may optionally be added)
This is a shared conversation. Sign in to Orris to start your own chat.